248
Views
2
CrossRef citations to date
0
Altmetric
Clinical Features - <italics>Review</italics>

Analysis of anticoagulation reversal survey (ARES)

ORCID Icon, & ORCID Icon
Pages 123-127 | Received 17 Jan 2020, Accepted 06 Apr 2020, Published online: 15 Apr 2020

References

  • Rowe AS, Mahbubani PS, Bucklin MH, et al. Activated prothrombin complex concentrate versus plasma for reversal of warfarin-associated hemorrhage. Pharmacotherapy. 2016 Nov;36(11):1132–1137. .
  • Rowe AS, Dietrich SK, Phillips JW, et al. Activated prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for vitamin K-antagonist reversal. Crit Care Med. 2018 Jun;46(6):943–948. .
  • Pruthi RK. Four-factor prothrombin complex concentrates for warfarin reversal: do real-world outcomes differ from controlled clinical trials? Transfusion. 2016 Apr;56(4):784–786.
  • Berndtson AE, Huang WT, Box K, et al. A new kid on the block: outcomes with Kcentra 1 year after approval. J Trauma Acute Care Surg. 2015 Dec;79(6):1004–1008. .
  • Tran HA, Chunilal SD, Tran H. An update of consensus guidelines for warfarin reversal. Med J Aust. 2014 Feb 3;200(2):82.
  • Hanger HC, Geddes JA, Wilkinson TJ, et al. Warfarin-related intracerebral haemorrhage: better outcomes when reversal includes prothrombin complex concentrates. Intern Med J. 2013 Mar;43(3):308–316. .
  • Voils SA, Baird B. Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: does it matter? Thromb Res. 2012 Dec;130(6):833–840.
  • Varga C, Al-Touri S, Papadoukakis S, et al. The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin. Transfusion. 2013 Jul;53(7):1451–1458. quiz 1450.
  • Chapman SA, Irwin ED, Beal AL, et al. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Ann Pharmacother. 2011 Jul;45(7–8):869–875. .
  • Kuwashiro T, Yasaka M, Itabashi R, et al. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis. 2011;31(2):170–176. .
  • Tran H, Collecutt M, Whitehead S, et al. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Intern Med J. 2011 Apr;41(4):337–343. .
  • Wojcik C, Schymik ML, Cure EG. Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy. Int J Emerg Med. 2009 Nov 26;2(4):217–225.
  • Goldstein JN, Rosand J, Schwamm LH. Warfarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocrit Care. 2008;9(2):277–283.
  • Siddiq F, Jalil A, McDaniel C, et al. Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage. Neurocrit Care. 2008;8(1):36–41. .
  • Lankiewicz MW, Hays J, Friedman KD, et al. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost. 2006 May;4(5):967–970. .
  • Crawford JH, Augustson BM. Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed? Med J Aust. 2006 Apr 3;184(7):365–366.
  • Cartmill M, Dolan G, Byrne JL, et al. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg. 2000 Oct;14(5):458–461. .
  • Hung A, Singh S, Tait RC. A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol. 2000 Jun;109(3):537–539.
  • Baglin T. Management of warfarin (coumarin) overdose. Blood Rev. 1998 Jun;12(2):91–98.
  • Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997 Mar;77(3):477–480. .
  • Shetty HG, Backhouse G, Bentley DP, et al. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. Thromb Haemost. 1992 Jan 23;67(1):13–15.
  • Zweifler AJ. Thrombus growth under the influence of warfarin and after abrupt reversal of its effects. Angiology. 1968 Mar;19(3):135–140.
  • Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor xa inhibitors. N Engl J Med. 2019 Apr 4;380(14):1326–1335.
  • Pollack CV Jr., Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med. 2017 Aug 3;377(5):431–441.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.